chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt little worse than he did after recieving the first 2 doses of vaccine Moderna; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt little worse than he did after recieving the first 2 doses of vaccine Moderna) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Felt little worse than he did after recieving the first 2 doses of vaccine Moderna). At the time of the report, VACCINATION COMPLICATION (Felt little worse than he did after recieving the first 2 doses of vaccine Moderna) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product included Blood pressure medications.  No treatment was received.  Patient reported that, she felt little worse than he did (her husband) after receiving the first 2 doses of the Moderna vaccine.   This case was linked to MOD-2021-378121 (Patient Link).
After sitting for 15 minutes, pt got up to wait for Mom in the waiting room while sibling was being evaluated, and became lightheaded and pale. She was lowered to the floor by the MA, and another MA went to get the nurse. Pt did not lose consciousness but states that everything got muffled and dark. Pt rested with legs elevated and ice pack behind head for approx 10 minutes, sat up, felt better. She was given cranberry juice, and left with mom once she felt well.
Patient was given a Hepatitis B (Heplisav-B) vaccine. Pt was supposed to receive the first dose for the HPV (Gardasil-9) vaccine. Pt was notified of error.
Pt vaccinated with MMR developed fever to 105F after innoculation, maculo papular blotches in face, also oral mucosa with white asians.
1/30/2021 vaccine given. 2/2/2021 rash on body and upper lip swollen. 2/3/2021 rash and swelling gone. 2/4/2021 swollen upper lip. 2/5/2021 no reactions.
troponin: high troponin levels; pain on the back of her head and her back; pain on the back of her head and her back; Chills; fever; She was shaking badly; Fainted; This is a spontaneous report from a contactable consumer. A 74-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 24Mar2021 11:15 (Lot Number: ER8727; Expiration Date: 31Jul2021) as SINGLE DOSE for covid-19 immunisation (Age at vaccination: 74 years). Medical history included ongoing rheumatoid arthritis, melanoma, depression, heart attack (had a heart attack 7 or 8 years ago) and covid (covid in the first week of January). Concomitant medications included levothyroxine sodium (SYNTHROID) and escitalopram oxalate (LEXAPRO) for depression. The patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 03Mar2021 for covid-19 immunisation and experienced rash with itching and a lump and swelling (74 years). The patient fainted on 24Mar2021, chills and fever on 24Mar2021 20:00, pain on the back of her head and her back and a couple of places like anyone would get when they fall on 25Mar2021 and she was shaking badly on 24Mar2021. The patient underwent lab tests and procedures which included blood work: unknown results and troponin: high troponin levels on an unspecified date. Therapeutic measures were taken as a result of tremor included Aleve. Outcome of the events chills and pyrexia was recovered on 25Mar2021 (four hours) while outcome of the events head pain and back pain was recovering. Outcome of the remaining events was unknown.
on evening of vaccine receipt, had red, itchy 2.5 inch area around injecton site. Took Benadryl; it worsened and on 2/13/21, had red, swollen area "size of an egg" at injection site. Itchiness worsened 2/14/21. In a.m. 2/14/21, both hands numb, then left arm numb and cold with "stabbing pain" in left arm. Numbness in left arm resolved by bed time 2/14/21  after intermittent numbness throughout day. As of 2/17/21, less itchiness at injections site ,but still reddened. No recurrence of numbness.
Soreness and swelling at injection site; Soreness and swelling at injection site; Malaise; feels tired; This is a spontaneous report from a Pfizer-sponsored program. A contactable other HCP (Patient) reported for a 61-year-old female patient received the first dose of BNT162b2 (lot: EK92331), intramuscular at left arm on 04Jan2021 (approximately between 18:15-18:30) at single dose for covid-19 immunization. Medical history was none. The patient's concomitant medications included supplements. The patient experienced soreness and swelling at injection site, malaise and feels tired on 05Jan2021 08:00. She was scheduled for second dose a day later for COVID vaccine so after the 21 days to get her second dose. Patient is a Dental Hygienist. She received the first dose on 04Jan2021 and is scheduled to receive second dose on 26Jan2021. She should have it scheduled for 25Jan2021. There is no prescriber. She received it at a local hospital through her employer. They did not offer her the 25Jan2020, and said next day is 26 days. They told her there would not be any problem being a day late. She called back with a concern and had evening appointment with the intention of being 3 weeks later. She did it while she had 2 days off work in case she had a reaction. She was told it was not a big deal to get it 1 days later. She asked if she could go to a different location and they told her no, it had to come from the same batch and lot to receive second dose. She is just concerned about doing it a day before she has to go back to work because there are worse side effects with second dose. There is a 4 day grace period from what she read of of 17-21 days and not over 21 days. She is not sure if that is true though. The outcome of the events was not recovered.
Headache; joint pain; palpitation; chest pain; This is a spontaneous report from a contactable other healthcare professional. A 40-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0158) via an unspecified route of administration on 08Apr2021(at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medications within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced headache, joint pain, palpitation and chest pain. It was unknown whether any therapeutic measures were taken as a result of the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events headache, joint pain, palpitation and chest pain was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
some drops on her arm; drops on the side of the syringe; invalid dose; This spontaneous case was reported by a pharmacist and describes the occurrence of MEDICATION ERROR (some drops on her arm), SYRINGE ISSUE (drops on the side of the syringe) and UNDERDOSE (invalid dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history was not reported.     On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced MEDICATION ERROR (some drops on her arm), SYRINGE ISSUE (drops on the side of the syringe) and UNDERDOSE (invalid dose). On 25-Feb-2021, MEDICATION ERROR (some drops on her arm), SYRINGE ISSUE (drops on the side of the syringe) and UNDERDOSE (invalid dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided by the reporter. No Treatment history was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: NNI On 21-May-2021: NNI On 21-May-2021: NNI; Sender's Comments: This report refers to a case of Underdose for mRNA-1273, lot # 031M20A with no associated AEs.
extreme cold and hot; no appetite; sleeping a lot; still feeling ill; in bed for roughly 7 days; pain; sweating; extreme fatigue; severe fever of 100.4 / fever that produces sweat; shivers; pain in the knees; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWEATING FEVER (fever that produce sweat), FEELING OF BODY TEMPERATURE CHANGE (extreme cold and hot), DECREASED APPETITE (no appetite), HYPERSOMNIA (sleeping a lot) and MALAISE (still feeling ill) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWEATING FEVER (fever that produce sweat), FEELING OF BODY TEMPERATURE CHANGE (extreme cold and hot), DECREASED APPETITE (no appetite), HYPERSOMNIA (sleeping a lot), MALAISE (still feeling ill), BEDRIDDEN (in bed for roughly 7 days), HYPERHIDROSIS (sweating), FATIGUE (extreme fatigue), PYREXIA (still not able to get the fever under control it is between 100.2 to 100.4), PAIN (pain), CHILLS (shivers) and ARTHRALGIA (pain in the knees). At the time of the report, SWEATING FEVER (fever that produce sweat), FEELING OF BODY TEMPERATURE CHANGE (extreme cold and hot), DECREASED APPETITE (no appetite), HYPERSOMNIA (sleeping a lot), MALAISE (still feeling ill), BEDRIDDEN (in bed for roughly 7 days), HYPERHIDROSIS (sweating), FATIGUE (extreme fatigue), PYREXIA (still not able to get the fever under control it is between 100.2 to 100.4), PAIN (pain), CHILLS (shivers) and ARTHRALGIA (pain in the knees) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       the patient takes thyroid medication; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
redness, soreness & swelling rt deltoid 3 1/4" x 2";
Stoffnest on neclk on left side. no treatment, gets worse as the weather is getting colder and during wet weather. Its becoming more difficult to ture head to the left side .  On 11/7/21 neck pained all day, Condition is becoming progressive worse.
Severe post-nasal drip followed by nausea and itching of mouth and throat.  Next day symptoms were improved but experienced flushing of face and swelling of eyes.  Also had rash around eyes.  Took Benadryl and relieved symptoms.  Also had low-grade fever.  Felt exceptionally ill on the Wednesday following vaccination and had rash on upper thighs which disappeared after approximately 6 hours.  Other than ongoing nausea, no further symptoms.
Patient received the vaccine on Sunday 3/14/21, and called 3/17/21 to report that she had chest tightness and a fever. Went to her doctors office on 3/17 and tested positive for COVID via nasal swab.  Was given Medrol and a Z-Pak.
both eyes iris changed the color from blue to green; This spontaneous case was reported by a consumer and describes the occurrence of EYE COLOUR CHANGE (both eyes iris changed the color from blue to green) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced EYE COLOUR CHANGE (both eyes iris changed the color from blue to green). At the time of the report, EYE COLOUR CHANGE (both eyes iris changed the color from blue to green) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications was not provided.; Sender's Comments: Based on the current available information which includes a temporal association between the use of mRNA-1273 and the start date of the reported events, a causal relationship with the event cannot be excluded
Chills; Headache; Site pain; Body ache; This is a Spontaneous report from a contactable Nurse (patient). A 41-years-old female patient (no pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , intramuscular on 09Jan2021 08:45 (lot number EL0142) at the second single dose, intramuscular on 21Dec2020 11:15 (lot number EH9899) at the first single dose for covid-19 immunisation. Anatomical location was left arm.  Medical history reported as none.  The patient's concomitant medications were not reported.  The patient experienced chills, headache, site pain, body ache on 09Jan2021 21:00.  The patient underwent lab tests and procedures which included Covid testing viral RNA: negative on 04Jun2020 via Nasal Swab. The outcome of events was unknown.No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination
Dizziness. Vertigo. Going from laying down to standing or sitting up. Or just lifting or turning my head. Nauseous the day after but only the day after.
Breakthrough case admission after three vaccines: Moderna 1/26/21 Lot# 007M20A;  Moderna 2/25/21 Lot# 024M20A;  Moderna 11/22/21 Lot# 939903.
SEVERE STROKE; This spontaneous report received from a consumer via social media concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was strong and was still capable old man. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose and start therapy date was not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced severe stroke. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0; 20210817368-covid-19 vaccine ad26.cov2.s severe stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event
PT GIVEN MODERNA VACCINE AND IS ONLY 16.  SHOULD HAVE BEEN GIVEN PFIZER VACCINE.  THIS IS THE 2ND DOSE IN THE SERIES BUT THE FIRST DOSE WAS PFIZER.  PT HAS HAD NO SIDE EFFECTS.
Sore throat; Felt tired; Ache; This is a spontaneous report received via contactable consumer or other non-health care professional (parent).A 20-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration administered in Arm Left on 26May2021 16:00 as single dose for COVID-19 immunization.Medical history included irritable bowel syndrome from an unknown date and unknown if ongoing from two years. The patient concomitant medications were not reported.The patient experienced felt tired, ache on 27May2021 and sore throat on 28May2021. Clinical course reported as stated that the caller is calling about her 20 year old daughter who received the first dose of the Pfizer Biontech COVID- 19 vaccine on 26May2021, felt tired and achy. This morning she woke up with a sore throat. She would like to know if this was a reported side effect with the Pfizer Biontech COVID-19 vaccine. Caller also added that she would like to know if the symptoms with the second dose of the Pfizer Biontech COVID-19 vaccine are more important than the ones with the first dose of the Pfizer Biontech COVID-19 vaccine. The events were assessed as non-serious. The daughter is planning to receive the next dose on 18JUN2021.The outcome of the event felt tired and ache was reported as recovering while for sore throat it was reported as not recovered.  Follow -up attempts are needed. Information on the lot/batch number has been requested.
When called to reschedule her 2nd dose patient stated she has pain on her left arm including at the site of  1st dose injection.  Patient stated she has been taking pain medication since 4/09/2021
RN went to give the patient a shot and the serum leaked out the connection between the needle syringe. The rn administered another dose of the vaccine because she felt that the patient did not get any of the first vaccine. Patient agreed and was fine getting another needle poke.
Stabbing chest pains a few hours after vaccine administered. Continued throughout the evening. Contacting PCP and he suggested going to ER.
experiencing an adverse event; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (experiencing an adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced ADVERSE EVENT (experiencing an adverse event). At the time of the report, ADVERSE EVENT (experiencing an adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
23 week pregnant patient received varivax vaccine by medical assistant which is contraindicated during pregnancy. Midwife intended to order varivax titer; this was misunderstood by medical assistant.
Patient states post vax on  3/10/00 he started experiencing general aches and sore muscles all over.
I went to my doctor and found that my bloodwork was abnormal. She sent me to a hematologist, for my anemia and high platelets. The hematologist ran more bloodwork, bone scan, bone marrow biopsy, CT scan of my abdomen and pelvis. All tests came back negative, I was then referred to a rheumatologist. The rheumatologist ran bloodwork for many different autoimmune diseases, all tests came back negative. He determined that I have polymyalgia rheumatica, started me on prednisone, dose pack. The prednisone has really helped, I will be seeing him for a follow up visit next week.
Fatigue; sweating; chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 46 year-old patient received bnt162b2 (BNT162B2) (Lot number: 301558A) at the age of 46 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1, No Events reported), for COVID-19 immunization; Bnt162b2 (Dose: 2, No Events reported), for COVID-19 immunization. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Fatigue"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "sweating"; CHILLS (non-serious), outcome "unknown", described as "chills".  No follow-up attempts are possible. No further information is expected.
About 4 hours following vaccines child began arching back and screaming/crying. He was inconsolable for 4 hours straight and refused to breastfeed or be held. He became rigid and developed a fever around 101 degrees F.
Administered 2nd covid dose 5-11 year old Pfizer vaccine to 14 year old.
This spontaneous report was received from a licensed practical nurse and refers to unspecified patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # M000442, expiry date: 31-MAR-2018, dose and route of administration were not reported). No symptoms were reported. Administered doses of vaccines experienced the temperature excursion of 32 degrees Fahrenheit for 15 minutes and 31 degrees Fahrenheit for 15 minutes. Data logger was involved. There were no previous excursions reported. Follow up information has been received from the nurse on 08-MAY-2017. This case refers to 7 month old patient, who was vaccinated with improperly stored doses of RECOMBIVAX HB and ROTATEQ (lot # L046319, expiry date: 28-SEP-2017, dose and route of administration were not reported) on 16-AUG-2016. Reporting nurse did know why the temperature excursions occurred but there were no further excursions. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1608USA012908: US-009507513-1608USA012794: US-009507513-1608USA012794: US-009507513-1705USA004965: US-009507513-1608USA012908: Original case: 1608USA012916. US-009507513-1705USA004967: US-009507513-1705USA004960: US-009507513-1705USA004973: US-009507513-1705USA004952: Original case 1608USA012916 US-009507513-1705USA004954: US-009507513-1705USA004953: Original Case: 1608USA012916.
I developed my symptoms while on a cruise. I was on a cruise ship and got tested and was negative. My husband was also displaying symptoms of COVID-19 symptoms. I tested for COVID-19 on 04/18/2023. I will retest tomorrow hoping to be negative. I had coughing and sore throat. I also have alot of muscular pain and joint pain, general malaise.  On 04/18/2023 I also called my provider to let her know of my symptoms.
Pt. states that after receiving the 3rd Booster of Phizer 08/23/2021, started experiencing symptoms of nerve pain in the toes, 7-10days later cloudiness in both ears. Ears continue to have symptoms, Primary visits, Emergency Room visit, 4 separate ENT specialists visit from 09/2021 - Present. 2 rounds of Anti-Biotics and 2 rounds of Steroids, still continuing to experience symptoms.
This case involves patient (unknown age and gender) who got the flu (influenza), after receiving INFLUENZA VACCINE. It was unknown if the patient had any medical history, concomitant disease or risk factor. Medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination. On an unknown date, the patient got the flu (influenza, non-serious), four days following the administration of INFLUENZA VACCINE. It was reported "Got it got the flu four days later still down with it" It was unknown if the patient experienced any additional symptoms/events. There were no lab data/results available. It was not reported if the patient received a corrective treatment. At time of reporting, the outcome was unknown for the reported event. There will be no information available on the batch number for this case.